Stopping a medical research project for financial reasons

Nephrology Dialysis Transplantation

Volumn 18, Issue 10, 2003, Pages 1982-1983

  Drüeke, Tilman B ^a   Descamps Latscha, Béatrice ^a   Locatelli, Francesco ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b A MANZONI HOSPITAL   (Italy)

Author keywords

Discontinuation; Financial reasons; Research project; Stopping

Indexed keywords

ACETYLCYSTEINE; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DRUG MANUFACTURE; DRUG MARKETING; DRUG RESPONSE; EDITORIAL; FINANCIAL MANAGEMENT; HEMODIALYSIS; HUMAN; MEDICAL RESEARCH; MONEY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

CLINICAL TRIALS; COST SAVINGS; COSTS AND COST ANALYSIS; ECONOMICS, MEDICAL; FEMALE; HUMANS; ITALY; MALE; NEPHROLOGY; RESEARCH SUPPORT;

EID: 18244431813     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg469     Document Type: Editorial

References (8)

1. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989; 6: 593-97
2. Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 2003; 60: 6-20
3. Sen CK, Rankinen T, Vaisanen S, Rauramaa R. Oxidative stress after human exercise: effect of N-acetylcysteine supplementation. J Appl Physiol 1994; 76: 2570-2577
4. Witko-Sarsat V, Gausson V, Nguyen A et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int 2003; 64: 82-91
5. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988; 319: 1557-1562
6. Psaty BM, Rennie D. Stopping medical research to save money. J Am Med Assoc 2003; 289: 2128-2131
7. Boyd K. Commentary: early discontinuation violates Helsinki principles. Br Med J 2001; 322: 605-606
8. Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation 2003; 107: 992-995